News

 

NEWS

Magnets offer hope for people with sleep apnea

Magnets offer hope for people with sleep apnea February 16, 2017 Please read the original post by Tim Didion at abc7news.com SAN FRANCISCO (KGO) — For most of us, eight hours of sleep is rejuvenating. For others, it can be torture. “I would wake up multiple times a night, throwing up. I hadn’t been breathing for over a minute. And […]

Read more

Japanese chemical firm Toray partners with QB3@953 to pursue breakthroughs in treatment of neurological diseases

Japanese chemical firm Toray partners with QB3@953 to pursue breakthroughs in treatment of neurological diseases San Francisco, CA, May 11, 2017 – QB3@953, the Bay Area’s premier life science incubator, welcomes Japan’s chemical giant Toray as its newest partner. The arrangement offers Toray the opportunity to nurture its budding pharmaceutical enterprise while bringing new expertise and trans-Pacific relationships to QB3@953’s […]

Read more

How This AgTech Startup Is Giving Farmers Insight Into Their Soil’s Health

How This AgTech Startup Is Giving Farmers Insight Into Their Soil’s Health July 11, 2017 Please read the original post by Alex Knapp at forbes.com AgTech startup Trace Genomics began offering their custom soil health kit to farmers about a year ago. Their aim? To give their customers insights into how healthy their soil is. Its process is pretty simple […]

Read more

AMGEN and QB3@953 announce winners of the AMGEN GOLDEN TICKET

AMGEN AND QB3@953 ANNOUNCE WINNERS OF THE AMGEN GOLDEN TICKET San Francisco, CA, June 11, 2017 – Two Diagnostic Companies Will Receive Lab Space and Other Benefits at San Francisco Life Sciences Incubator Amgen (NASDAQ: AMGN) and QB3@953 today announced that Darmiyan and Enable Biosciences have won the Amgen Golden Ticket at QB3@953. Each company receives one year of lab […]

Read more

Indee Labs closed a $1.3M angel round

  Indee Labs closed a $1.3M angel round Indee Labs recently closed a $1.3M angel round and demonstrated functional modification of human primary T-cells with high efficiency (30 to 60%), cell viability (>85%) and recovery (>90%) without T-cell exhaustion or activation. The team also signed its first customer — a clinical-stage biotechnology company developing gene-modified B-cell therapies for rare disease […]

Read more

These seven researchers are changing the face of biotech

These seven researchers are changing the face of biotech Read the complete article at BizJournals Three of the Magnificent 7 are women CEOs at QB3@953 which we want to highlight in our post. June 8, 2017, Bay Area Biotech From common-but-stubborn ailments like acne to the future of gene therapy or personalized cancer care, the breadth of biotech innovation happening […]

Read more

GraphWear presented SweatSmart beta at the NASDAQ

GraphWear presented SweatSmart beta at the NASDAQ GraphWear presented SweatSmart beta at the NASDAQ bell closing ceremony along with the CEO of the 49ers, Jed York and were featured on Times Square. This is the first time in human history that players would be able to extract their health information in real-time without blood pricks and they are excited to […]

Read more

OneSkin closes $2M Financing to reverse aging skin

  OneSkin closes $2M Financing to reverse aging skin OneSkin Technologies is working on optimizing their technology of in vitro tissue aging and quantitative measurement of anti-aging molecule effects over the age of skin models. This platform will allow them to screen for molecules that molecules that truly rejuvenate skin or prevent aging.

Read more

New Core Equipment: GE WAVE 25

New Core Equipment: GE WAVE 25 The WAVE 25 bioreactor system will allow QB3@953 startups to reliably and repeatedly grow up to 25L of cells for protein production. The single use bags standardize production and eliminates the need for clean-rooms, all of which saves time and money. We are dedicated to helping our researchers get reliable data fast – and […]

Read more

QB3@953 Companies Attract $1.36B In Capital

QB3@953 Companies Attract $1.36B In Capital San Francisco, CA, May 1, 2017 – QB3@953 proved definitively that its incubator facilities allow life science startups to progress at lightening speed, making a huge impact on the life-science ecosystem of the Bay Area. QB3@953 tenant and alumni companies are thriving. In the three short years since its founding, QB3@953 companies attracted $1.36Bn […]

Read more
Page 1 of 812345...Last »

Upcoming Event

  • Scalable Microbiome Diagnostics for Agriculture

    12:30-13:30
    09/21/2017
    1st Floor Conference Room, GEHC
    953 Indiana Street, San Francisco, CA 94107, United States
    AMGEN Lunch Seminar Diane Wu, PhD and Poornima Parameswaran, PhD Co-Founders, Trace Genomics RSVP The Trace Genomics microbiome sequencing platform enables screening of disease-causing microbes and interpretation of millions of beneficial organisms in the soil. Their machine learning platform enables simple integration of soil microbiome information into with field management information to help farmers identify optimal management conditions that increase soil health and sustainability as well as crop yields. Their innovative technology has received notable media coverage in Forbes, TechCrunch, Wall Street Journal, AgFunder, and Fast Company, and was most recently listed by Forbes as one of the 25 most innovative Ag Tech startups. About Diane Wu Diane Wu, PhD completed a BSc in Computer Science and Molecular Biology at SFU (Vancouver, Canada) and a PhD in Genetics at Stanford University. She was awarded a Stanford Graduate Fellowship and published her thesis on the cover of Nature Structural Molecular Biology, advised by Nobel Laureate Dr. Andrew Fire. Diane then joined the machine learning team at Palantir Technologies as one of their first data scientists, where she built predictive models for healthcare, merchandising, law enforcement, and fraud detection.
    About Poornima Parameswaran Poornima Parameswaran, PhD completed her BS in Molecular Biology at UT Austin, a PhD in Microbiology & Immunology at Stanford University with Nobel Laureate Dr. Andrew Fire, and her postdoctoral fellowship with MacArthur Fellow Dr. Eva Harris at UC Berkeley's school of Public Health, where she also worked with the Ministry of Health in Nicaragua. She has been an author on eleven publications (371+ citations), where she used NGS technologies in novel ways to address fundamental questions in pathogen-host interactions.

Address

953 Indiana St., San Francisco, CA 94107
Tel: (415)-347-8287
Map

Sign-Up for our Newsletter